Citation only
via OpenAlex
Glycated Alpha-Synuclein Assemblies Cause Distinct Parkinson’s Disease Pathogenesis in Mice
Akshaya Rajan, Anish Varghese, Shaliya Puthanveedu Hashardeen, Ann Teres Babu, Vinesh Vijayan, Poonam Singh Thakur
ACS Chemical Neuroscience · 2025 · ▲ 3 citations
Abstract
Alpha-synuclein (α-Syn) misfolding and aggregation are key drivers of Parkinson's disease (PD) pathology. Mutations and certain post-translational modifications impact its aggregation propensity and pathogenicity. Glycation, a nonenzymatic modification enhanced during hyperglycemia and aging, both known risk factors for PD, has been implicated in α-Syn pathology. Although preformed α-Syn fibrils induce PD-like phenotypes in mice, the impact of glycation on their pathogenicity is unclear. In the current study, we glycated α-Syn using methylglyoxal (MGO), a potent glycating agent, resulting in altered biophysical characteristics in comparison to nonglycated α-Syn. Glycation inhibited the formation of typical β sheet structures under aggregating conditions. Despite that, glycated α-Syn assemblies induced dopaminergic neurodegeneration and neuroinflammation to a similar extent as the nonglycated α-Syn fibrils upon their injection in the mouse substantia nigra (SN). However, these glycated assemblies triggered higher neuroinflammation and increased accumulation of receptor for advanced glycation end products (RAGE) compared to nonglycated fibrils. Consequently, an earlier onset of neuromuscular deficits and anxiety was observed in these mice. Thus, glycation of α-Syn causes distinct PD-associated pathology compared to nonglycated α-Syn, causing an earlier onset of motor symptoms. These findings provide insight into how the glycation of α-Syn due to hyperglycemia may contribute to an increased risk of PD in diabetic populations.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1021/acschemneuro.5c00428
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Rajan, A., Varghese, A., Hashardeen, S.P., Babu, A.T., Vijayan, V., & Thakur, P.S. (2025). Glycated Alpha-Synuclein Assemblies Cause Distinct Parkinson’s Disease Pathogenesis in Mice. <em>ACS Chemical Neuroscience</em>. https://doi.org/10.1021/acschemneuro.5c00428
Vancouver
Rajan A, Varghese A, Hashardeen SP, Babu AT, Vijayan V, Thakur PS. Glycated Alpha-Synuclein Assemblies Cause Distinct Parkinson’s Disease Pathogenesis in Mice. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.5c00428.
BibTeX
@article{akshaya2025Glycat,
title = {Glycated Alpha-Synuclein Assemblies Cause Distinct Parkinson’s Disease Pathogenesis in Mice},
author = {Akshaya Rajan and Anish Varghese and Shaliya Puthanveedu Hashardeen and Ann Teres Babu and Vinesh Vijayan and Poonam Singh Thakur},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.5c00428},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Alzheimer’s Disease & Parkinsonism 2017
Open access · CC-BY
Endothelial Degeneration of Parkinson's Disease is Related to Alpha-Synuclein Aggregation
Biochemical and Biophysical Research Communications 2025
Open access · CC-BY
Enhanced alpha-synuclein pathology and exacerbated motor dysfunction in alpha-synuclein transgenic mice with autophagy deficiency
Translational Neurodegeneration 2018
Open access · CC-BY
Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
Trends in Molecular Medicine 2012
Preprint · OA
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Acta Neuropathologica Communications 2021
Open access · CC-BY
Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
Experimental and Therapeutic Medicine 2023
Open access · CC-BY